{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:21:32Z","timestamp":1790083292550,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5055-5","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T03:28:18Z","timestamp":1542684498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Fangfang","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaosu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"5055_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.radonc.2011.12.028","volume":"104","author":"JK Tuan","year":"2012","unstructured":"Tuan JK, Ha TC, Ong WS, Siow TR, Tham IW, Yap SP, et al. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiother Oncol. 2012;104:305\u201311.","journal-title":"Radiother Oncol."},{"key":"5055_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijrobp.2004.11.002","volume":"62","author":"SA Yeh","year":"2005","unstructured":"Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 2005;62:672\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0360-3016(92)90740-9","volume":"23","author":"AW Lee","year":"1992","unstructured":"Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hed.24645","volume":"39","author":"OSH Chan","year":"2017","unstructured":"Chan OSH, Sze HCK, Lee MCH, Chan LLK, Chang ATY, Lee SWM, et al. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma. Head & neck. 2017;39:533.","journal-title":"Head & neck"},{"key":"5055_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ijrobp.2007.03.012","volume":"69","author":"DT Chua","year":"2007","unstructured":"Chua DT, Wei WI, Sham JS, Hung KN, Au GK. Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007;69:469\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0360-3016(00)00463-6","volume":"47","author":"TW Leung","year":"2000","unstructured":"Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, SK O. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;47:405\u201312.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1040-8428(99)00069-4","volume":"33","author":"WI Wei","year":"2000","unstructured":"Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma. Crit Rev Oncol Hematol. 2000;33:91\u20138.","journal-title":"Crit Rev Oncol Hematol"},{"key":"5055_CR8","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ejca.2012.06.016","volume":"48","author":"YJ Hua","year":"2012","unstructured":"Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, et al. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer. 2012;48:3422\u20138.","journal-title":"Eur J Cancer."},{"key":"5055_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clon.2011.11.010","volume":"24","author":"F Han","year":"2012","unstructured":"Han F, Zhao C, Huang SM, Lu LX, Huang Y, Deng XW, et al. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 2012;24:569\u201376.","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"5055_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125351","volume":"10","author":"W Xiao","year":"2015","unstructured":"Xiao W, Liu S, Tian Y, Guan Y, Huang S, Lin C, et al. Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy. PLoS One. 2015;10:e0125351.","journal-title":"PLoS One"},{"key":"5055_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073918","volume":"8","author":"HY Chen","year":"2013","unstructured":"Chen HY, Ma XM, Ye M, Hou YL, Xie HY, Bai YR. Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma. PLoS One. 2013;8:e73918.","journal-title":"PLoS One"},{"key":"5055_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.radonc.2005.10.010","volume":"77","author":"DT Chua","year":"2005","unstructured":"Chua DT, Sham JS, Leung LH, Au GK. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005;77:290\u20134.","journal-title":"Radiother Oncol."},{"key":"5055_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/hed.23880","volume":"38","author":"YM Tian","year":"2016","unstructured":"Tian YM, Guan Y, Xiao WW, Zeng L, Liu S, Lu TX, et al. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma. Head & neck. 2016;38:225\u201331.","journal-title":"Head & neck."},{"key":"5055_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0360-3016(03)01508-6","volume":"58","author":"TX Lu","year":"2004","unstructured":"Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ijrobp.2011.07.006","volume":"83","author":"S Qiu","year":"2012","unstructured":"Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;83:676\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/archotol.128.3.280","volume":"128","author":"WE Fee Jr","year":"2002","unstructured":"Fee WE Jr, Moir MS, Choi EC, Goffinet D. Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg. 2002;128:280\u20134.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"5055_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<215::AID-HED2>3.0.CO;2-B","volume":"22","author":"WW King","year":"2000","unstructured":"King WW, Ku PK, Mok CO, Teo PM. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head & neck. 2000;22:215\u201322.","journal-title":"Head & neck."},{"key":"5055_CR18","doi-asserted-by":"publisher","first-page":"P67","DOI":"10.1016\/j.otohns.2010.06.087","volume":"143","author":"A Vlantis","year":"2010","unstructured":"Vlantis A, Chan HS, Yu BKH, Tong MCF, Hasselt CAV. Nasopharyngectomy for recurrent NPC: a multivariate analysis. Otolaryngol Head Neck Surg. 2010;143:P67\u2013P8.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5055_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.oraloncology.2013.05.003","volume":"50","author":"JY Chan","year":"2014","unstructured":"Chan JY. Surgical management of recurrent nasopharyngeal carcinoma. Oral Oncol. 2014;50:913\u20137.","journal-title":"Oral Oncol"},{"key":"5055_CR20","first-page":"719754","volume":"2012","author":"JX Li","year":"2012","unstructured":"Li JX, Lu TX, Huang Y, Han F. Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area. TheScientificWorldJOURNAL. 2012;2012:719754.","journal-title":"TheScientificWorldJOURNAL"},{"key":"5055_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ijrobp.2004.03.021","volume":"60","author":"DC Oksuz","year":"2004","unstructured":"Oksuz DC, Meral G, Uzel O, Cagatay P, Turkan S. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys. 2004;60:388\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0360-3016(98)00164-3","volume":"41","author":"JM Hwang","year":"1998","unstructured":"Hwang JM, Fu KK, Phillips TL. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1998;41:1099\u2013111.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.oraloncology.2013.12.005","volume":"50","author":"TM Hung","year":"2014","unstructured":"Hung TM, Chen CC, Lin CY, Ng SH, Kang CJ, Huang SF, et al. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Oral Oncol. 2014;50:228\u201333.","journal-title":"Oral Oncol"},{"issue":"Suppl 2","key":"5055_CR24","first-page":"C179","volume":"11","author":"F Jiang","year":"2015","unstructured":"Jiang F, Jin T, Feng XL, Jin QF, Chen XZ. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: the Zhejiang Cancer Hospital's experience. J Cancer Res Ther. 2015;11(Suppl 2):C179\u201384.","journal-title":"J Cancer Res Ther"},{"key":"5055_CR25","first-page":"814948","volume":"2014","author":"W Wang","year":"2014","unstructured":"Wang W, Feng M, Fan Z, Li J, Lang J. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014;2014:814948.","journal-title":"Biomed Res Int"},{"key":"5055_CR26","doi-asserted-by":"crossref","first-page":"38381","DOI":"10.18632\/oncotarget.5420","volume":"6","author":"X Ou","year":"2015","unstructured":"Ou X, Zhou X, Shi Q, Xing X, Yang Y, Xu T, et al. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost. Oncotarget. 2015;6:38381\u201397.","journal-title":"Oncotarget"},{"key":"5055_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","volume":"110","author":"X Sun","year":"2014","unstructured":"Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398\u2013403.","journal-title":"Radiother Oncol."},{"key":"5055_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.03.015","volume":"69","author":"LR Wu","year":"2017","unstructured":"Wu LR, Liu YT, Jiang N, Fan YX, Wen J, Huang SF, et al. Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol. 2017;69:26\u201332.","journal-title":"Oral Oncol"},{"key":"5055_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0360-3016(02)02760-8","volume":"53","author":"CY Hsiung","year":"2002","unstructured":"Hsiung CY, Yorke ED, Chui CS, Hunt MA, Ling CC, Huang EY, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:638\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5055_CR30","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/ijms18122749","volume":"18","author":"W Hur","year":"2017","unstructured":"Hur W, Yoon SK. Molecular pathogenesis of radiation-induced cell toxicity in stem cells. Int J Mol Sci. 2017;18:2749.","journal-title":"Int J Mol Sci"},{"key":"5055_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stem.2010.06.014","volume":"7","author":"M Mohrin","year":"2010","unstructured":"Mohrin M, Bourke E, Alexander D, Warr MR, Barryholson K, Beau MML, et al. Hematopoietic stem cell quiescence promotes error prone DNA repair and mutagenesis. Cell Stem Cell. 2010;7:174.","journal-title":"Cell Stem Cell"},{"key":"5055_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.seminhematol.2016.11.001","volume":"54","author":"I Beerman","year":"2017","unstructured":"Beerman I. Accumulation of DNA damage in the aged hematopoietic stem cell compartment. Semin Hematol. 2017;54:12.","journal-title":"Semin Hematol"},{"key":"5055_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrc1950","volume":"6","author":"RMB oslash","year":"2006","unstructured":"oslash RMB. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702\u201313.","journal-title":"Nat Rev Cancer"},{"key":"5055_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semradonc.2008.11.005","volume":"19","author":"RP Coppes","year":"2009","unstructured":"Coppes RP, Van dGA, Lombaert IM. Stem cell therapy to reduce radiation-induced normal tissue damage. Semin Radiat Oncol. 2009;19:112.","journal-title":"Semin Radiat Oncol"},{"key":"5055_CR35","first-page":"51","volume":"20","author":"M Benderitter","year":"2013","unstructured":"Benderitter M, Caviggioli F, Chapel A, Coppes R, Guha C, Klinger M, et al. Stem cell therapies for the treatment of radiation-induced normal tissue side effects. European Journal on Criminal Policy & Research. 2013;20:51\u201372.","journal-title":"European Journal on Criminal Policy & Research"},{"key":"5055_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.mcn.2004.07.010","volume":"27","author":"J Llad\u00f3","year":"2004","unstructured":"Llad\u00f3 J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol. Cell. Neurosci. 2004;27:322\u201331.","journal-title":"Mol. Cell. Neurosci."},{"key":"5055_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5966\/sctm.2011-0019","volume":"1","author":"G Ren","year":"2012","unstructured":"Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y, et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med. 2012;1:51\u20138.","journal-title":"Stem Cells Transl Med"},{"key":"5055_CR38","doi-asserted-by":"publisher","first-page":"165ra4","DOI":"10.1126\/scitranslmed.3004579","volume":"4","author":"YD Teng","year":"2012","unstructured":"Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, et al. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med. 2012;4:165ra4.","journal-title":"Sci Transl Med"},{"key":"5055_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/stem.459","volume":"28","author":"J Tolar","year":"2010","unstructured":"Tolar J, Blanc KL, Keating A, Blazar BR. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells. 2010;28:1446\u201355.","journal-title":"Stem Cells"},{"key":"5055_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909293106","volume":"106","author":"MM Acharya","year":"2009","unstructured":"Acharya MM, Christie LA, Lan ML, Donovan PJ, Cotman CW, Fike JR, et al. Rescue of Radiation-Induced Cognitive Impairment through cranial transplantation of human embryonic stem cells. Proc Natl Acad Sci U S A. 2009;106:19150.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5055_CR41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/HP.0b013e3181c9f79a","volume":"98","author":"M Benderitter","year":"2010","unstructured":"Benderitter M, Gourmelon P, Bey E, Chapel A, Clairand I, Prat M, et al. New emerging concepts in the medical management of local radiation injury. Health Phys. 2010;98:851.","journal-title":"Health Phys"},{"key":"5055_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.soncn.2006.04.004","volume":"22","author":"M Mcquestion","year":"2006","unstructured":"Mcquestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs. 2006;22:163\u201373.","journal-title":"Semin Oncol Nurs"},{"key":"5055_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0278-2391(83)90294-X","volume":"41","author":"RE Marx","year":"1983","unstructured":"Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283\u20138.","journal-title":"J Oral Maxillofac Surg."},{"key":"5055_CR44","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hed.20753","volume":"30","author":"KY Cheng","year":"2008","unstructured":"Cheng KY, Lee KW, Chiang FY, Ho KY, Kuo WR. Rupture of radiation-induced internal carotid artery pseudoaneurysm in a patient with nasopharyngeal carcinoma-spontaneous occlusion of carotid artery due to long-term embolizing performance. Head & neck. 2008;30:1132\u20135.","journal-title":"Head & neck."},{"key":"5055_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.otohns.2003.08.010","volume":"130","author":"HC Chen","year":"2004","unstructured":"Chen HC, Lin CJ, Jen YM, Juan CJ, Hsueh CJ, Lee JC, et al. Ruptured internal carotid pseudoaneurysm in a nasopharyngeal carcinoma patient with skull base osteoradionecrosis. Otolaryngol Head Neck Surg. 2004;130:388\u201390.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5055_CR46","first-page":"828","volume":"87","author":"FY Lin","year":"1988","unstructured":"Lin FY, Lin JW, Chang H, Yan CL. Pseudoaneurysm of common carotid artery after irradiation: report of a case. Taiwan Yi Xue hui Za Zhi. J Formos Med Assoc. 1988;87:828.","journal-title":"J Formos Med Assoc"},{"key":"5055_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/(SICI)1097-0347(199905)21:3<211::AID-HED5>3.0.CO;2-C","volume":"21","author":"JS Mok","year":"1999","unstructured":"Mok JS, Marshall JN, Chan M, van Hasselt CA. Percutaneous embolization to control intractable epistaxis in nasopharyngeal carcinoma. Head & neck. 1999;21:211.","journal-title":"Head & neck."},{"key":"5055_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1440-1622.2000.01795.x","volume":"70","author":"WK Mak","year":"2000","unstructured":"Mak WK, Chow TL, Kwok SP. Radionecrosis of internal carotid artery in nasopharyngeal carcinoma presenting as epistaxis. Aust N Z J Surg. 2000;70:237\u20138.","journal-title":"Aust N Z J Surg"},{"key":"5055_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hed.21036","volume":"31","author":"YJ Hua","year":"2009","unstructured":"Hua YJ, Chen MY, Qian CN, Hong MH, Zhao C, Guo L, et al. Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head & neck. 2009;31:807\u201312.","journal-title":"Head & neck."},{"key":"5055_CR50","doi-asserted-by":"crossref","first-page":"43450","DOI":"10.18632\/oncotarget.15896","volume":"8","author":"YM Tian","year":"2017","unstructured":"Tian YM, Huang WZ, Yuan X, Bai L, Zhao C, Han F. The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy. Oncotarget. 2017;8:43450\u20137.","journal-title":"Oncotarget"},{"key":"5055_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0167-8140(99)00177-2","volume":"54","author":"JT Chang","year":"2000","unstructured":"Chang JT, See LC, Liao CT, Ng SH, Wang CH, Chen IH, et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2000;54:135\u201342.","journal-title":"Radiother Oncol."},{"key":"5055_CR52","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/1097-0142(19911115)68:10<2120::AID-CNCR2820681005>3.0.CO;2-7","volume":"68","author":"R Choo","year":"1991","unstructured":"Choo R, Tannock I. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret hospital experience. Cancer. 1991;68:2120\u20134.","journal-title":"Cancer"},{"key":"5055_CR53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/bjc.1993.312","volume":"68","author":"V Gebbia","year":"1993","unstructured":"Gebbia V, Zerillo G, Restivo G, Speciale R, Cupido G, Lo Bue P, et al. Chemotherapeutic treatment of recurrent and\/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases. Br J Cancer. 1993;68:191\u20134.","journal-title":"Br J Cancer"},{"key":"5055_CR54","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.3747\/co.20.1456","volume":"20","author":"T Xu","year":"2013","unstructured":"Xu T, Tang J, Gu M, Liu L, Wei W, Yang H. Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge. Curr Oncol. 2013;20:e406\u201319.","journal-title":"Curr Oncol."},{"key":"5055_CR55","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.coc.0000180389.86104.68","volume":"28","author":"DT Chua","year":"2005","unstructured":"Chua DT, Sham JS, Au GK. Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma. Am J Clin Oncol. 2005;28:464\u201371.","journal-title":"Am J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5055-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5055-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T15:23:12Z","timestamp":1605453792000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5055-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5055"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5055-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Boards of Fudan University Shanghai Cancer Center, China. Written informed consent was obtained from the patients before treatment. Due to the retrospective design of the study, the local ethic committee confirmed that informed consent was not necessary from participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1139"}}